Fabio Cataldi
Chief Tech/Sci/R&D Officer chez LANDOS BIOPHARMA, INC.
Fortune : - $ au 31/03/2024
Profil
Fabio Cataldi is currently the Chief Medical Officer & Executive Vice President at Landos Biopharma, Inc. He previously worked as the Senior Director-Gastroenterology Biotherapeutics at Pfizer Inc. from 2010 to 2015.
He also held the position of Vice President & Head-Gastroenterology at Arena Pharmaceuticals, Inc. Additionally, he served as the VP-Clinical Development in Internal Medicine at Shire Japan KK from 2015 to 2017.
Dr. Cataldi obtained a doctorate degree from the University of Campania Luigi Vanvitelli.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
LANDOS BIOPHARMA, INC.
-.--% | 31/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Fabio Cataldi
Sociétés | Poste | Début |
---|---|---|
LANDOS BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 05/09/2022 |
Anciens postes connus de Fabio Cataldi
Sociétés | Poste | Fin |
---|---|---|
Shire Japan KK
Shire Japan KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Japan KK is a Japanese pharmaceutical company that manufactures pharmaceuticals. The private company is based in Tokyo, Japan. | Corporate Officer/Principal | 01/07/2017 |
PFIZER, INC. | Corporate Officer/Principal | 01/07/2015 |
ARENA PHARMACEUTICALS | Corporate Officer/Principal | - |
Formation de Fabio Cataldi
University of Campania Luigi Vanvitelli | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
PFIZER, INC. | Health Technology |
LANDOS BIOPHARMA, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Shire Japan KK
Shire Japan KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Japan KK is a Japanese pharmaceutical company that manufactures pharmaceuticals. The private company is based in Tokyo, Japan. | Health Technology |